LPL Financial
MRVI icon

LPL Financial’s Maravai LifeSciences MRVI Stock Holding History

LPL Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.7K Sell
10,366
-1,072
-9% -$4.63K ﹤0.01% 5991
2026
Q1 		$32.4K Buy
+11,438
New +$38.8K ﹤0.01% 5828
2024
Q4 		– Sell
-35,173
Closed -$292K – 5393
2024
Q3 		$292K Buy
35,173
+8,759
+33% +$75.7K ﹤0.01% 4449
2024
Q2 		$189K Buy
26,414
+4,645
+21% +$40.1K ﹤0.01% 4588
2024
Q1 		$189K Buy
21,769
+593
+3% +$4.01K ﹤0.01% 4523
2023
Q4 		$139K Sell
21,176
-1,121
-5% -$7.24K ﹤0.01% 4484
2023
Q3 		$223K Buy
22,297
+1,145
+5% +$12.6K ﹤0.01% 4155
2023
Q2 		$263K Buy
21,152
+330
+2% +$4.45K ﹤0.01% 3960
2023
Q1 		$292K Buy
20,822
+7,899
+61% +$113K ﹤0.01% 3766
2022
Q4 		$185K Buy
12,923
+2,544
+25% +$40.1K ﹤0.01% 4017
2022
Q3 		$265K Buy
+10,379
New +$260K ﹤0.01% 3707
2022
Q1 		– Sell
-5,889
Closed -$247K – 4325
2021
Q4 		$247K Sell
5,889
-150
-2% -$6.08K ﹤0.01% 3836
2021
Q3 		$296K Sell
6,039
-921
-13% -$44.9K ﹤0.01% 3660
2021
Q2 		$290K Buy
+6,960
New +$270K ﹤0.01% 3614

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

LPL Financial's MRVI Position: Q2 2026 in Review

LPL Financial reduced its Maravai LifeSciences (MRVI) stake by 9.4% in Q2 2026, selling an estimated $4.63K and leaving 10,366 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5991.

LPL Financial first reported a position in MRVI in Q2 2021 and has held it in 14 quarters since. The position peaked at $296K in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • LPL Financial held 10,366 shares of Maravai LifeSciences worth $64.7K as of Q2 2026.
  • LPL Financial sold 1,072 Maravai LifeSciences shares in Q2 2026, an estimated $4.63K.
  • Maravai LifeSciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5991 holding.
  • LPL Financial first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 14 quarters since.
  • LPL Financial's Maravai LifeSciences position peaked at $296K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.